| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/01/2010 | US20100081703 Tri-demethylation-capable protein complex, method of its preparation and its use |
| 04/01/2010 | US20100081702 Pharmaceutical composition for prophylaxis or treatment of hepatitis |
| 04/01/2010 | US20100081701 FAP inhibitors |
| 04/01/2010 | US20100081700 Hepatitis C Virus Inhibitors |
| 04/01/2010 | US20100081699 Yeast platform construction and screening methods |
| 04/01/2010 | US20100081697 Crystalline freebase of 4'-{2-ethoxy-4-ethyl-5-[((S)-2-mercapto-4-methylpentanoylamino)methyl]imidazol-1-ylmethyl}-3'-fluorobiphenyl-2-carboxylic acid; stability; high melting point; nondeliquescent; hypotensive agents; heart failure; angiotensin II type 1 receptor antagonist; enkephalinase inhibitor |
| 04/01/2010 | US20100081696 Fluoro substituted cycloalkanoindoles, compositions containing such compounds and methods of treatment |
| 04/01/2010 | US20100081695 2-N-{5-[ [4-[2-(methyl-2-pyridinylamino) ethoxy] phenyl]methyl]-2,4-thiazolidinedione) butanedioic acid, methods of preparation and compositions with rosiglitazone maleate |
| 04/01/2010 | US20100081694 Composition comprising at least one ppar agonist and a lipid component |
| 04/01/2010 | US20100081693 Thiadiazole compound and use thereof |
| 04/01/2010 | US20100081692 Novel 1-Benzyl-4-Piperidinamines that are Useful in the Treatment of COPD and Asthma |
| 04/01/2010 | US20100081691 Multicyclic compounds and methods of their use |
| 04/01/2010 | US20100081690 Oxazole derivatives as positive allosteric modulators of metabotropic glutamate receptors |
| 04/01/2010 | US20100081689 Methods and Compositions for the Treatment of Iron Toxicity |
| 04/01/2010 | US20100081688 Process for the preparation of montelukast, and intermediates therefor |
| 04/01/2010 | US20100081687 Biarylcarboxyarylamides as vanilloid-1 receptor modulators |
| 04/01/2010 | US20100081686 Pyridone derivatives having a binding activity to the cannabinoid type 2 recepter |
| 04/01/2010 | US20100081685 Pharmaceutical composition |
| 04/01/2010 | US20100081684 Methods for treating inflammatory disorders |
| 04/01/2010 | US20100081683 Nicotinic acetylcholine receptor sub-type selective amides of diazabicycloalkanes |
| 04/01/2010 | US20100081682 39-Desmethoxy Derivatives of Rapamycin |
| 04/01/2010 | US20100081681 Methods and compositions for preventing or treating age-related diseases |
| 04/01/2010 | US20100081680 N-sulfonamido polycyclic pyrazolyl compounds |
| 04/01/2010 | US20100081678 Indole compounds and their use as radiation sensitizing agents and chemotherapeutic agents |
| 04/01/2010 | US20100081677 Heteroarylamide pyrimidone derivatives |
| 04/01/2010 | US20100081676 Selective proton coupled folate transporter and folate receptor, and garftase inhibitor compounds and methods of using the same |
| 04/01/2010 | US20100081675 Fused multicyclic compounds as protein kinase inhibitors |
| 04/01/2010 | US20100081674 Fused heterocyclic derivative, pharmaceutical composition comprising the derivative, and use of the composition for medical purposes |
| 04/01/2010 | US20100081673 Heteroaryl antagonists of prostaglandin d2 receptors |
| 04/01/2010 | US20100081672 Ph sensitive matrix formulation |
| 04/01/2010 | US20100081671 Cycloalkylamine substituted isoquinoline derivatives |
| 04/01/2010 | US20100081670 N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases |
| 04/01/2010 | US20100081669 Pressure sensitive adhesive matrix device or system for the treatment or prevention of onychomycosis or tinea pedis |
| 04/01/2010 | US20100081668 Polymorphs of 5--6-chloro-1,3-dihydro-2h-indol-2-one hydrobromide and processes for preparation thereof |
| 04/01/2010 | US20100081667 Chemical Compounds |
| 04/01/2010 | US20100081666 Src activation for determining cancer prognosis and as a target for cancer therapy |
| 04/01/2010 | US20100081665 Anti-Malarial Compounds |
| 04/01/2010 | US20100081664 Method of therapeutic administration of dhe to enable rapid relief of migraine while minimizing side effect profile |
| 04/01/2010 | US20100081663 Method of therapeutic administration of dhe to enable rapid relief of migraine while minimizing side effect profile |
| 04/01/2010 | US20100081662 Pyrrolotriazine kinase inhibitors |
| 04/01/2010 | US20100081661 Heme oxygenase inhibitors, screening methods for heme oxygenase inhibitors and methods of use of heme oxygenase inhibitors for antimicrobial therapy |
| 04/01/2010 | US20100081660 Novel Compounds Having Selective Inhibiting Effect at GSK3 |
| 04/01/2010 | US20100081659 Sigma receptor inhibitors |
| 04/01/2010 | US20100081658 Heterocyclic antiviral compounds |
| 04/01/2010 | US20100081657 Quinoxalines useful as inhibitors of protein kinases |
| 04/01/2010 | US20100081656 Compositions and methods for modulating c-kit and pdgfr receptors |
| 04/01/2010 | US20100081655 Reverse-turn mimetics and method relating thereto |
| 04/01/2010 | US20100081654 Oncogenic-RAS-signal dependent lethal compounds |
| 04/01/2010 | US20100081653 2-[1H-Benzimidazol-2(3H)-ylidene]-2-(pyrimidin-2-yl)acetamides and 2-[benzothiazol-2(3H)-ylidene]-2-(pyrimidin-2-yl)acetamides as kinase inhibitors |
| 04/01/2010 | US20100081652 Cinnamoyl Compound and Use Thereof |
| 04/01/2010 | US20100081651 R(-)-11-hydroxyaporphine derivatives and uses thereof |
| 04/01/2010 | US20100081650 Antimicrobial Compounds |
| 04/01/2010 | US20100081649 Treatment of cancers with methylol-containing compounds and at least one electrolyte |
| 04/01/2010 | US20100081648 Methods for Characterizing and Treating Cognitive Impairment In Aging and Disease |
| 04/01/2010 | US20100081647 Short-acting benzodiazepine salts and their polymorphic forms |
| 04/01/2010 | US20100081646 Bicyclic heteroaryl inhibitors of pde4 |
| 04/01/2010 | US20100081645 Tricyclic heteroaryl compounds useful as inhibitors of janus kinase |
| 04/01/2010 | US20100081644 Compounds Which Selectively Modulate The CB2 Receptor |
| 04/01/2010 | US20100081643 Novel cyclic benzimidazole derivatives useful as anti-diabetic agents |
| 04/01/2010 | US20100081642 Cb-1 receptor modulator pharmaceutical formulations |
| 04/01/2010 | US20100081641 Imidazolidinonyl aminopyrimidine compounds for the treatment of cancer |
| 04/01/2010 | US20100081640 Pharmaceutical composition |
| 04/01/2010 | US20100081639 Pharmaceutical composition comprising fermented ginseng |
| 04/01/2010 | US20100081638 Compositions comprising an extract of tiarella polyphylla or compounds isolated therefrom for preventing and treating cancer diseases |
| 04/01/2010 | US20100081637 Eczema treatment with vitamin D and analogs thereof method, composition and cream |
| 04/01/2010 | US20100081635 Compounds for treating proliferative disorders |
| 04/01/2010 | US20100081634 Novel Phosphorus-Containing Thyromimetics |
| 04/01/2010 | US20100081633 Derivatives of 1-amino-2-cyclobutylethylboronic acid |
| 04/01/2010 | US20100081632 High-content and high throughput assays for identification of lipid-regulating pathways, and novel therapeutic agents for lipid disorders |
| 04/01/2010 | US20100081631 Methods and compositions for treating gastrointenstial disorders |
| 04/01/2010 | US20100081630 Heparin Compositions and Selectin Inhibition |
| 04/01/2010 | US20100081629 Low molecular weight heparins including at least one covalent bond with biotin or a biotin derivative, method for making same and use thereof |
| 04/01/2010 | US20100081628 Nucleoside cyclicphosphates |
| 04/01/2010 | US20100081627 Polymeric nucleoside prodrugs |
| 04/01/2010 | US20100081626 Weight loss compositions and uses thereof |
| 04/01/2010 | US20100081625 Methods for preventing and treating neurodegenerative disorders |
| 04/01/2010 | US20100081623 Novel tellurium compounds and their use as immunomodulators |
| 04/01/2010 | US20100081621 Crystal structure of the catalytic domain of the viral restriction factor APOBEC3G |
| 04/01/2010 | US20100081618 Transporters Comprising Spaced Arginine Moieties |
| 04/01/2010 | US20100081612 Polypeptide derivatives of parathyroid hormone (pth) |
| 04/01/2010 | US20100081610 Matrix metalloproteinase inhibitors |
| 04/01/2010 | US20100081192 Early prostate cancer antigens (epca), polynucleotide sequences encoding them, and their use |
| 04/01/2010 | US20100080864 Treatment and composition for achieving skin anti-aging benefits by corneum protease activation |
| 04/01/2010 | US20100080863 Dietary Composition and Method of Using the Same |
| 04/01/2010 | US20100080862 Compositions and foods for improving lipid metabolism |
| 04/01/2010 | US20100080860 Application of short-chain monocarboxylic acids for crop protection |
| 04/01/2010 | US20100080856 Method and composition for postoperative wound healing |
| 04/01/2010 | US20100080855 Hedgehog signaling and cancer stem cells in hematopoietic cell malignancies |
| 04/01/2010 | US20100080851 Method of preparing a microcapsule containing unsaturated fatty acids, the microcapsule prepared by the method, and articles containing the microcapsule |
| 04/01/2010 | US20100080849 Pellets containing a pharmaceutical substance, method for the production thereof and use of the same |
| 04/01/2010 | US20100080847 Medicinal compositions quickly disintegrating in the oral cavity and process for producing the same |
| 04/01/2010 | US20100080844 Method to enhance an immune response of nucleic acid vaccination |
| 04/01/2010 | US20100080843 Natural and synthetic sulfur and selenium analogs and polymer conjugated forms thereof for the modulation of angiogenesis |
| 04/01/2010 | US20100080842 Transdermal extended-delivery donepezil compositions and methods for using the same |
| 04/01/2010 | US20100080836 Method and means for culturing osteoblastic cells |
| 04/01/2010 | US20100080835 Implantable device for the delivery of risperidone and methods of use thereof |
| 04/01/2010 | US20100080830 Systemic delivery of antiviral agents |
| 04/01/2010 | US20100080829 Lyophilized pharmaceutical compositions and methods of making and using same |
| 04/01/2010 | US20100080828 Immunogenic sequences |
| 04/01/2010 | US20100080817 HUMAN PAPILLOMAVIRUS / Ii-KEY HYBRIDS AND METHODS OF USE |